Schedule 13D ownership disclosure

Pacira BioSciences Inc

Common Stock, par value $0.001 per share · CUSIP: 695127100

Event date: 2026-03-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • DOMA PERPETUAL CAPITAL MANAGEMENT LLCReported CIK 0001962221

    Shares: 2,777,794 · Class: 6.9%

  • DOMA1 LLC

    Shares: 2,777,794 · Class: 6.9%

  • DOMA Perpetual LO Equity Master Fund LP

    Shares: 1,965,775 · Class: 4.9%

  • DOMA Perpetual Partners GP LLC

    Shares: 1,965,775 · Class: 4.9%

  • Pedro Escudero

    Shares: 2,936,794 · Class: 7.3%

  • The John Templeton Foundation

    Shares: 812,019 · Class: 2%

  • DOMA2 LLC

    Shares: 1,965,775 · Class: 4.9%

  • Eric de Armas

    Shares: 1,389 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-26-000180
Form type
SCHEDULE 13D/A
Filer
Doma Perpetual Capital Management LLC
CIK
CIK 1962221
Filed
Mar 12, 2026
Reporting period
Mar 11, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub